Direct oral anticoagulants (DOACs): From the laboratory point of view
Direct oral anticoagulants (DOACs) represent a new generation of drugs that have been increasingly used in the prevention and treatment of thromboembolic states. According to the mechanism of anticoagulant action, DOACs are divided into two groups: direct inhibitors of thrombin (dabigatran) and dire...
Saved in:
| Main Authors: | Margetić Sandra, Goreta Sandra Šupraha, Ćelap Ivana, Razum Marija |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2022-12-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2022-0034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023-11-01) -
Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
by: Peter W. Ketch, et al.
Published: (2024-12-01) -
Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation?
by: Domenico Laviola, et al.
Published: (2025-07-01) -
Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants
by: A. I. Mironova, et al.
Published: (2022-06-01) -
Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022
by: A. V. Matveev, et al.
Published: (2024-01-01)